- Trials with a EudraCT protocol (29)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
29 result(s) found for: Reconstructive surgery.
Displaying page 1 of 2.
EudraCT Number: 2016-005057-21 | Sponsor Protocol Number: PECBRIL2016 | Start Date*: 2017-06-08 |
Sponsor Name:Hospital Universitario Sant Joan de Reus | ||
Full Title: A prospective, randomized, parallel comparative clinical trial comparing the safety of perioperative analgesic efficacy of the PEC II block with BRILMA in breast surgery.Version 4, of May 16, 2017 | ||
Medical condition: Non-reconstructiva Breast Surgery candidates | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001016-35 | Sponsor Protocol Number: ZUH-UMPR-MICB | Start Date*: 2019-05-29 | |||||||||||||||||||||
Sponsor Name:Associate Professor, Consultant Jens Børglum | |||||||||||||||||||||||
Full Title: The ultrasound-guided multiple-injection costotransverse block for mastectomy and primary reconstructive surgery. A double blind, randomised, placebo controlled trial. | |||||||||||||||||||||||
Medical condition: Postoperative pain following mastectomy and reconstructive surgery due to breast cancer. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000910-39 | Sponsor Protocol Number: BRTR1 | Start Date*: 2018-12-13 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE | ||||||||||||||||||
Full Title: Efficacy of tranexamic acid in reducing post-operative bleeding in oncologic-reconstructive breast surgery | ||||||||||||||||||
Medical condition: Post-operative hematoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001829-76 | Sponsor Protocol Number: ProsMaMa13.1 | Start Date*: 2013-10-04 | |||||||||||
Sponsor Name:Paula Diéguez García | |||||||||||||
Full Title: INTERCOSTAL BRANCHES BLOCK IN THE MIDAXILLARY LINE VERSUS PARAVERTEBRAL BLOCK, ULTRASOUND-GUIDED FOR NOT RECONSTRUCTIVE BREAST SURGERY. RANDOMIZED CLINICAL TRIAL | |||||||||||||
Medical condition: Sheduled patients for nor reconstructive unilateral breast surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-005186-31 | Sponsor Protocol Number: 01062017 | Start Date*: 2018-06-06 | ||||||||||||||||
Sponsor Name:Department of Plastic Surgery, Breast and Burns Treatment | ||||||||||||||||||
Full Title: Fat Grafting with Ex-Vivo Expanded Adipose-Derived Stem Cells for Breast Reconstruction Following Mastectomy | ||||||||||||||||||
Medical condition: This study will include patients with genetic predisposition to development of breast cancer, who are offered prophylactic bilateral skin-sparring mastectomy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004738-14 | Sponsor Protocol Number: NanoGSkin-CB-2019 | Start Date*: 2020-04-28 | ||||||||||||||||
Sponsor Name:Red Andaluza de Diseño y Traslación de Terapias Avanzadas - Fundación Pública Andaluza Progreso y Salud | ||||||||||||||||||
Full Title: PHASE II CLINICAL TRIAL EVALUATING THE SAFETY AND EFFICACY OF A TISSUE ENGINEERED AUTOLOGOUS SKIN SUBSTITUTE RECONSTRUCTIVE SURGERY FOR BASAL CELL CARCINOMA. | ||||||||||||||||||
Medical condition: Reconstructive skin surgery in basal cell cancer (Mohs surgery) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002165-19 | Sponsor Protocol Number: 20177308 | Start Date*: 2019-05-10 |
Sponsor Name:Medical University Vienna | ||
Full Title: Neo-BCC trial: Neoadjuvant treatment of difficult to resect, locally advanced basal cell carcinoma (BCC) with Talimogene laherparepvec (T-VEC) | ||
Medical condition: Basal cell carcinoma (BCC) is the most common malignant neoplasm in fair skinned humans (Rubin et al., 2005). Over the last decades its incidence has increased (Chinem and Miot, 2011). Especially w... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005075-14 | Sponsor Protocol Number: 1.0 | Start Date*: 2013-11-25 |
Sponsor Name:Medizinische Universität Wien | ||
Full Title: Minimal local anaesthetic volumes for sciatic nerve blockade: A clinical evaluation of ED99 volumes | ||
Medical condition: Patients scheduled for forefoot surgery are performed an ultrasound guided block. We will evaluate the clinical application of previously evaluated experimental data regarding volume reduction of L... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004669-41 | Sponsor Protocol Number: RG_15-011 | Start Date*: 2020-05-11 |
Sponsor Name:University of Birmingham | ||
Full Title: STAR-TREC: Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer | ||
Medical condition: Early rectal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000073-37 | Sponsor Protocol Number: Version 1 FFF | Start Date*: 2008-09-24 |
Sponsor Name:Oxford Radcliffe Hospitals NHS Trust | ||
Full Title: Assessment of the effects of pressors on graft blood flow after free tissue transfer surgery | ||
Medical condition: Patients in need of free flap facial reconstructive surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002244-25 | Sponsor Protocol Number: ICG20 | Start Date*: 2012-07-05 | ||||||||||||||||
Sponsor Name:Norfolk & Norwich University Hospital | ||||||||||||||||||
Full Title: Prospective feasibility study for the evaluation of indocyanine green and near-infrared imaging in sentinel lymph node biopsy for cutaneous melanoma patients: The "RED-GREEN-BLUE" melanoma study. | ||||||||||||||||||
Medical condition: Cutaneous Melanoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004236-19 | Sponsor Protocol Number: PUB2014 | Start Date*: 2015-02-13 | |||||||||||
Sponsor Name:Landstinget i Östergötland | |||||||||||||
Full Title: Pudendal block after posterior vaginal surgery. A randomized controlled trial on postoperative pain. | |||||||||||||
Medical condition: postoperative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004052-20 | Sponsor Protocol Number: CKTO 2005-25R | Start Date*: 2006-11-01 | |||||||||||
Sponsor Name:Koningin Wilhelmina Fonds | |||||||||||||
Full Title: Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy study | |||||||||||||
Medical condition: advanced stage squamous cell cancer of the vulva | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002459-40 | Sponsor Protocol Number: BREAST-AB-01 | Start Date*: 2020-12-17 |
Sponsor Name:Rigshospitalet | ||
Full Title: Prophylactic treatment of breast implants with a solution of gentamicin, vancomycin and cefazolin antibiotics for women undergoing breast reconstructive surgery: a randomized controlled trial (The ... | ||
Medical condition: Implant-based breast reconstruction following mastectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015533-79 | Sponsor Protocol Number: | Start Date*: 2010-02-08 |
Sponsor Name:Oxford Radcliffe Hospitals NHS Trust | ||
Full Title: An assessment of the effects of pressors on graft blood flow after free tissue transfer surgery: A randomised study – Part II | ||
Medical condition: Patients in need of free flap facial reconstructive surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-022971-79 | Sponsor Protocol Number: PALO-10-14 | Start Date*: 2011-05-23 | ||||||||||||||||
Sponsor Name:Helsinn Healthcare SA | ||||||||||||||||||
Full Title: A Multicenter, Double-blind, Double-dummy, Randomized, Parallel Group, Stratified Study to Evaluate the Efficacy and Safety of a Single IV Dose of Palonosetron Compared to a Single IV Dose of Ondan... | ||||||||||||||||||
Medical condition: Postoperative nausea and vomiting (PONV) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) PL (Completed) HU (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-002306-21 | Sponsor Protocol Number: P2014/PE2 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Hôpital Universitaire Des Enfants Reine Fabiola | |||||||||||||
Full Title: Monocentric, prospective randomized controlled clinical trial assessing the effect on the lower limb spinal motoneuron excitability, the efficacy in term of morphinic sparing and safety of of earl... | |||||||||||||
Medical condition: Peri and post operative pain management | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004961-26 | Sponsor Protocol Number: 12-009 | Start Date*: 2015-12-15 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:McMaster University | |||||||||||||||||||||||||||||||||||||||||||
Full Title: Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY): A Multi-Center Randomized Controlled Study Comparing Alternative Antibiotic Regimens in Patients Undergoing Tumor Resections with Endopro... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: ? Patients with a primary bone malignancy or soft-tissue sarcoma that has invaded a lower extremity bone that are undergoing surgical treatment to resect the tumor and functionally reconstruct the ... | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) AT (Completed) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000299-13 | Sponsor Protocol Number: NVD003-CLN01 | Start Date*: 2018-05-17 |
Sponsor Name:Novadip Biosciences | ||
Full Title: A prospective multicentre single-arm study in adults to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant NVD-003 for bone reconstruction for the treatment of rec... | ||
Medical condition: Patients with documented recalcitrant lower limb nonunion, meaning a single, meta- and/or diaphyseal nonunion defect of femur or tibia after at least one failed reconstructive surgical attempt. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Trial now transitioned) LU (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003007-35 | Sponsor Protocol Number: R2810-ONC-1901 | Start Date*: 2020-02-04 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2 Study of Neoadjuvant Cemiplimab for Stage II to IV (M0) Cutaneous Squamous Cell Carcinoma (CSCC) | |||||||||||||
Medical condition: Stage II to IV cutaneous squamous cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
